Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.
about
Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosisAbsent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinomaBasic research in kidney cancer.A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings
P2860
Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Harnessing innate and adaptive ...... erapy of renal cell carcinoma.
@en
Harnessing innate and adaptive ...... erapy of renal cell carcinoma.
@nl
type
label
Harnessing innate and adaptive ...... erapy of renal cell carcinoma.
@en
Harnessing innate and adaptive ...... erapy of renal cell carcinoma.
@nl
prefLabel
Harnessing innate and adaptive ...... erapy of renal cell carcinoma.
@en
Harnessing innate and adaptive ...... erapy of renal cell carcinoma.
@nl
P2093
P2860
P1476
Harnessing innate and adaptive ...... erapy of renal cell carcinoma.
@en
P2093
Bernhard Frankenberger
Christiane Geiger
Christine S Falk
Dolores J Schendel
Elfriede Nössner
Heike Pohla
P2860
P2888
P304
P356
10.1007/S00109-009-0455-2
P577
2009-03-07T00:00:00Z